KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Accounts Payables (2016 - 2025)

Biogen has reported Accounts Payables over the past 17 years, most recently at $432.0 million for Q4 2025.

  • Quarterly results put Accounts Payables at $432.0 million for Q4 2025, up 1.84% from a year ago — trailing twelve months through Dec 2025 was $432.0 million (up 1.84% YoY), and the annual figure for FY2025 was $432.0 million, up 1.84%.
  • Accounts Payables for Q4 2025 was $432.0 million at Biogen, up from $413.1 million in the prior quarter.
  • Over the last five years, Accounts Payables for BIIB hit a ceiling of $589.2 million in Q4 2021 and a floor of $354.5 million in Q2 2024.
  • Median Accounts Payables over the past 5 years was $423.4 million (2024), compared with a mean of $427.2 million.
  • Biggest five-year swings in Accounts Payables: rose 29.52% in 2021 and later fell 21.21% in 2024.
  • Biogen's Accounts Payables stood at $589.2 million in 2021, then fell by 16.58% to $491.5 million in 2022, then dropped by 17.95% to $403.3 million in 2023, then increased by 5.18% to $424.2 million in 2024, then increased by 1.84% to $432.0 million in 2025.
  • The last three reported values for Accounts Payables were $432.0 million (Q4 2025), $413.1 million (Q3 2025), and $408.4 million (Q2 2025) per Business Quant data.